Zabofloxacin Hydrochloride
Tier C — Watch / tradeZabofloxacin Hydrochloride
Targets：Topoisomerase IV、Bacterial DNA gyrase
Brand：Zabolante
Indications (approved)：慢性阻塞性肺疾病
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| ZABO-001 | 51814-19-8 | 1-benzyl 3-ethyl 4-oxopyrrolidine-1,3-dicarboxylate |
| ZABO-002 | - | 1-benzyl 3-ethyl 3-(hydroxymethyl)-4-oxopyrrolidine-1,3-dicarboxylate |
| ZABO-003 | 1620405-18-6 | (Z)-1-benzyl 3-ethyl 3-(hydroxymethyl)-4-(methoxyimino)pyrrolidine-1,3-dicarboxylate |
| ZABO-004 | - | (Z)-1-benzyl 3-ethyl 4-(methoxyimino)-3-(((methylsulfonyl)oxy)methyl)pyrrolidine-1,3-dicarboxylate |
| ZABO-005 | - | (E)-benzyl 3-(hydroxymethyl)-4-(methoxyimino)-3-(((methylsulfonyl)oxy)methyl)pyrrolidine-1-carboxylate |
| ZABO-006 | - | (E)-benzyl 3-(azidomethyl)-3-(hydroxymethyl)-4-(methoxyimino)pyrrolidine-1-carboxylate |
| ZABO-007 | - | (E)-benzyl 3-(azidomethyl)-4-(methoxyimino)-3-(((methylsulfonyl)oxy)methyl)pyrrolidine-1-carboxylate |
| ZABO-008 | 1825361-01-0 | (E)-benzyl 3-(aminomethyl)-4-(methoxyimino)-3-(((methylsulfonyl)oxy)methyl)pyrrolidine-1-carboxylate |
| ZABO-009 | 1825361-02-1 | (E)-benzyl 8-(methoxyimino)-2,6-diazaspiro[3.4]octane-6-carboxylate |
| ZABO-010 | - | (E)-6-benzyl 2-tert-butyl 8-(methoxyimino)-2,6-diazaspiro[3.4]octane-2,6-dicarboxylate |
| ZABO-011 | 219680-63-4 | (E)-tert-butyl 8-(methoxyimino)-2,6-diazaspiro[3.4]octane-2-carboxylate |
| ZABO-012 | 100361-18-0 | 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
| ZABO-013 | 219680-75-8 | (E)-7-(2-(tert-butoxycarbonyl)-8-(methoxyimino)-2,6-diazaspiro[3.4]octan-6-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
Frequently asked questions
What are the approved indications of Zabofloxacin Hydrochloride?
Approved indications include: 慢性阻塞性肺疾病.
When does the Zabofloxacin Hydrochloride patent expire?
No public expiry year is available for Zabofloxacin Hydrochloride yet; this page updates once verified.
How many synthesis routes are recorded for Zabofloxacin Hydrochloride?
1 synthesis routes are recorded; the shortest is 12 steps with 220.00 mg total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Zabofloxacin Hydrochloride intermediates?
All intermediates in Zabofloxacin Hydrochloride routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Zabofloxacin Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24